These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1319246)
1. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan. Kawai K; Kawai A Intern Med; 1992 Mar; 31(3):313-8. PubMed ID: 1319246 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to Epstein-Barr virus in patients with chronic fatigue. Matthews DA; Lane TJ; Manu P South Med J; 1991 Jul; 84(7):832-40. PubMed ID: 1648795 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response? Manian FA Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864 [TBL] [Abstract][Full Text] [Related]
4. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802 [TBL] [Abstract][Full Text] [Related]
5. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay. Swanink CM; van der Meer JW; Vercoulen JH; Bleijenberg G; Fennis JF; Galama JM Clin Infect Dis; 1995 May; 20(5):1390-2. PubMed ID: 7620030 [TBL] [Abstract][Full Text] [Related]
7. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers. Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG Front Immunol; 2019; 10():1946. PubMed ID: 31475007 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. Ikuta K; Yamada T; Shimomura T; Kuratsune H; Kawahara R; Ikawa S; Ohnishi E; Sokawa Y; Fukushi H; Hirai K; Watanabe Y; Kurata T; Kitani T; Sairenji T Microbes Infect; 2003 Oct; 5(12):1096-102. PubMed ID: 14554250 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. Nystad TW; Myrmel H J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144 [TBL] [Abstract][Full Text] [Related]
11. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Levine PH; Stemmermann G; Lennette ET; Hildesheim A; Shibata D; Nomura A Int J Cancer; 1995 Mar; 60(5):642-4. PubMed ID: 7860138 [TBL] [Abstract][Full Text] [Related]
12. [Viral infection and its causative role for chronic fatigue syndrome]. Okano M Nihon Rinsho; 1992 Nov; 50(11):2617-24. PubMed ID: 1337559 [TBL] [Abstract][Full Text] [Related]
13. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765 [TBL] [Abstract][Full Text] [Related]
14. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374 [TBL] [Abstract][Full Text] [Related]
15. Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome. Sumaya CV Rev Infect Dis; 1991; 13 Suppl 1():S19-25. PubMed ID: 1850540 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A Front Immunol; 2021; 12():656797. PubMed ID: 34867935 [TBL] [Abstract][Full Text] [Related]
17. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation. Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055 [TBL] [Abstract][Full Text] [Related]
18. [Chronic fatigue syndrome and virus infection: human herpesvirus 6 (HHV-6) infection]. Yamanishi K Nihon Rinsho; 1992 Nov; 50(11):2612-6. PubMed ID: 1337558 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population. Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036 [TBL] [Abstract][Full Text] [Related]